---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004501"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:40:38.749569+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals raises ~$1.39M in registered direct offering and private placement

## Summary
- Priced 568,000 common shares plus warrants for 568,000 shares at $2.45 per unit, gross proceeds ~$1.39M.
- Warrants exercisable at $2.32 per share, expire 5 years from issuance; subject to 4.99%/9.99% ownership limitation.
- Offering expected to close June 27, 2024; net proceeds for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners acting as financial advisor with 6.5% fee plus up to $80,000 expense reimbursement.

## SEC filing metadata
- accession: 0001683168-24-004501
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004501/0001683168-24-004501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004501/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004501
- JSON: https://secwatch.observer/filing/0001683168-24-004501.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.